Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 20Recruiting 7Terminated 4Active not recruiting 2Unknown 1No longer available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Advanced Solid Tumor 29Advanced Solid Tumors 20Mesothelioma 19Solid Tumor 18Mesothelioma, Malignant 18Solid Tumors 16Solid Tumor, Adult 11Melanoma 10Carcinoma, Non-Small-Cell Lung 10Ovarian Neoplasms 8Retinoblastoma 7Colorectal Neoplasms 7Carcinoma, Renal Cell 7Uterine Cervical Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Lung Neoplasms 6Cholangiocarcinoma 6Advanced Malignant Solid Neoplasm 6Triple Negative Breast Neoplasms 5Sarcoma 4Malignant Solid Neoplasm 4Locally Advanced or Metastatic Solid Tumors 4Hematopoietic and Lymphatic System Neoplasm 4Esophageal Neoplasms 4Advanced or Metastatic Solid Tumors 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Pancreatic Neoplasms 3Neoplasms 3Malignant Solid Tumor 3

Interventions

brigimadlin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Solid Tumours × Other solid neoplasm × Clear all
NCT06619509 2026-04-14

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

Boehringer Ingelheim

Phase 2 Active not recruiting
90 enrolled
Other solid neoplasm

Solid Tumours

NCT06589414 2026-02-10

DAMeGe

Institut Claudius Regaud

Phase NA Active not recruiting
171 enrolled
Other solid neoplasm

Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡